Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rutaecarpine Ameliorated High Sucrose-Induced Alzheimer's Disease Like Pathological and Cognitive Impairments in Mice
Zhao Bin, Yi Wang, Rui Liu, et al.
Rejuvenation Research (2020) Vol. 24, Iss. 3, pp. 181-190
Closed Access | Times Cited: 19

Showing 19 citing articles:

The TRPV1-PKM2-SREBP1 axis maintains microglial lipid homeostasis in Alzheimer’s disease
Xudong Sha, Jiayuan Lin, Kexin Wu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
Mei Wang, Wendi Huang, Juan Huang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20
Neuroprotective effect of transient receptor potential Vanilloid 1 agonist capsaicin in Alzheimer’s disease model induced with okadaic acid
Murat Çakır, Furkan Yüksel, Mahmut Ozkut, et al.
International Immunopharmacology (2023) Vol. 118, pp. 109925-109925
Closed Access | Times Cited: 15
Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
Dan Chen, Yun Sun
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access
Quinazolinones as Potential Anticancer Agents: Synthesis and Action Mechanisms
Zhili Deng, Jieming Li, Pengbo Zhu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 210-210
Open Access
Natural Products Targeting Tau Protein Phosphorylation: A Promising Therapeutic Avenue for Alzheimerʼs Disease
Ziying Chen, Lu Yan, Yiyun Wang, et al.
Planta Medica (2025)
Closed Access
Promising derivatives of rutaecarpine with diverse pharmacological activities
Deping Li, Ziqian Huang, Xiaojun Xu, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 7
Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
Tingting Zou, Cheng Zeng, Junyan Qu, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 15
5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3
Zhen Yu, Shixin Chan, Xu Wang, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 993-1006
Open Access | Times Cited: 6
Potential active compounds and common mechanisms of Evodia rutaecarpa for Alzheimer's disease comorbid pain by network pharmacology analysis
Huiyi Jiang, Jiamin Qiu, Xin Deng, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18455-e18455
Open Access | Times Cited: 5
Analysis of the Effect of the TRPC4/TRPC5 Blocker, ML204, in Sucrose-Induced Metabolic Imbalance
Mizael Calácio Araújo, Suzany H. S. Soczek, Jaqueline P. Pontes, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1100-1100
Open Access | Times Cited: 5
Rutaecarpine Mitigates Cognitive Impairment by Balancing Mitochondrial Function Through Activation of the AMPK/PGC1α Pathway
Min Gong, Jianping Jia
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6598-6612
Closed Access | Times Cited: 4
Rutaecarpine Inhibits U87 Glioblastoma Cell Migration by Activating the Aryl Hydrocarbon Receptor Signaling Pathway
Yiyun Liu, Yangsheng Chen, Ruihong Zhu, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 8
Effect of CYP3A inducer/inhibitor and licorice on hepatotoxicity and in vivo metabolism of main alkaloids of Euodiae Fructus based on UPLC-Q-Exactive-MS
Kun Ren, Ruijie Wang, Shinuo Fang, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 116005-116005
Closed Access | Times Cited: 6
Different ratios of Schisandra chinensis and Evodia rutaecarpa combination for treating Alzheimer’s disease
Qingyu Cao, Jiaqi Liu, Peiliang Dong, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 20, pp. 1877-1886
Open Access | Times Cited: 2
The study of therapeutic efficacy and mechanisms of Schisandra chinensis and Evodia rutaecarpa combined treatment in a rat model of Alzheimer's disease
Qingyu Cao, Jiaqi Liu, Chengguo Pang, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21942-e21942
Open Access | Times Cited: 2
Traditional Chinese Medicine in Alzheimer's Disease: From the Perspective of GSK-3β and Tau Hyperphosphorylation
Mei Wang, Wendi Huang, Juan Huang, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 13, pp. 100543-100543
Open Access
Rutaecarpine prevents the malignant biological properties of breast cancer cells by the miR-149-3p/S100A4 axis
Yi Xiong, Chao Xiong, Peng Li, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 17, pp. 930-930
Open Access | Times Cited: 1
Page 1

Scroll to top